Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury.

Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury.
复制标题

DOI:
10.1002/hep.23365
复制
发表时间:
2010-02
期刊:
影响因子:
13.5
通讯作者:
DeMatteo, Ronald P.
DeMatteo, Ronald P.
中科院分区:
医学1区
文献类型:
--
作者:
Bamboat, Zubin M.;Balachandran, Vinod P.;Ocuin, Lee M.;Obaid, Hebroon;Plitas, George;DeMatteo, Ronald P.

文献摘要

参考文献

被引文献

相似文献

内源性配体如高迁移率族蛋白1(HMGB 1)和核酸由死亡细胞释放并结合Toll样受体(TLR)。由于TLR 9通过检测细菌和内源性DNA位于微生物和无菌炎症的界面,我们研究了其在节段性肝缺血再灌注(I/R)损伤模型中的作用。在评估肝损伤、细胞因子和活性氧(ROS)之前,使小鼠经受1小时的缺血和12小时的再灌注。用抑制性CpG(iCpG)序列处理的野生型(WT)小鼠和TLR 9 −/−小鼠在肝脏I/R后血清丙氨酸氨基转移酶(ALT)和炎性细胞因子显著降低。肝损伤由骨髓来源的细胞介导,因为移植TLR 9 −/−骨髓的WT小鼠免受肝I/R损伤。WT小鼠的损伤部分依赖于中性粒细胞中的TLR 9信号传导,其增强ROS、IL-6和TNF的产生。在体外,从坏死肝细胞释放的DNA通过TLR 9依赖性机制增加肝非实质细胞(NPC)和中性粒细胞的细胞因子分泌。TLR 9和HMGB 1的抑制引起中性粒细胞培养物中最大的炎性细胞因子抑制,并赋予体内I/R损伤更大的保护作用。TLR 9作为组织坏死的内源性传感器,在肝脏I/R期间加剧先天性免疫应答。TLR 9和HMGB 1的联合阻断代表了限制I/R损伤的临床相关的新方法。
Endogenous ligands such as high-mobility group box 1 (HMGB1) and nucleic acids are released by dying cells and bind Toll-like receptors (TLRs). Because TLR9 sits at the interface of microbial and sterile inflammation by detecting both bacterial and endogenous DNA, we investigated its role in a model of segmental liver ischemia-reperfusion (I/R) injury. Mice were subjected to 1 h of ischemia and 12 h of reperfusion prior to assessment of liver injury, cytokines and reactive oxygen species (ROS). Wild-type (WT) mice treated with an inhibitory CpG (iCpG) sequence and TLR9−/− mice had markedly reduced serum alanine aminotransferase (ALT) and inflammatory cytokines following liver I/R. Liver damage was mediated by bone marrow derived cells as WT mice transplanted with TLR9−/− bone marrow were protected from hepatic I/R injury. Injury in WT mice partly depended on TLR9 signaling in neutrophils, which enhanced production of ROS, IL-6, and TNF. In vitro, DNA released from necrotic hepatocytes increased liver non-parenchymal cell (NPC) and neutrophil cytokine secretion via a TLR9-dependent mechanism. Inhibition of both TLR9 and HMGB1 caused maximal inflammatory cytokine suppression in neutrophil cultures and conferred even greater protection from I/R injury in vivo. TLR9 serves as an endogenous sensor of tissue necrosis that exacerbates the innate immune response during liver I/R. Combined blockade of TLR9 and HMGB1 represents a clinically relevant, novel approach to limiting I/R injury.
DOI: 10.1038/sj.mt.6300031
发表时间: 2007-02-01
期刊: MOLECULAR THERAPY
影响因子: 12.4
作者:
Cerullo, Vincenzo;Seiler, Michael P.;Lee, Brendan
通讯作者: Lee, Brendan
DOI: 10.1126/science.1168988
发表时间: 2009-03-27
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Chen GY;Tang J;Zheng P;Liu Y
通讯作者: Liu Y
DOI: 10.1172/jci114656
发表时间: 1990-06-01
影响因子: 15.9
作者:
COLLETTI, LM;REMICK, DG;CAMPBELL, DA
通讯作者: CAMPBELL, DA
DOI: 10.1016/s0002-9440(10)64456-2
发表时间: 2002-11-01
影响因子: 6
作者:
Kato, A;Gabay, C;Lentsch, AB
通讯作者: Lentsch, AB
DOI: 10.4049/jimmunol.173.1.230
发表时间: 2004-07-01
影响因子: 4.4
作者:
Katz, SC;Pillarisetty, VG;DeMatteo, RP
通讯作者: DeMatteo, RP